← 返回

原发性鼻窦黏膜黑色素瘤的形态学和免疫组化特征及其预后意义和治疗靶点:一项回顾性研究

英文原题:Morphological and Immunohistochemical Aspects with Prognostic Implications and Therapeutic Targets of Primary Sinonasal Mucosal Melanoma: A Retrospective Study.

查看英文原题

Morphological and Immunohistochemical Aspects with Prognostic Implications and Therapeutic Targets of Primary Sinonasal Mucosal Melanoma: A Retrospective Study.

PubMed 2024/08/16(内容时间) Cancers (Basel) Q2 · IF 4.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

鼻黏膜黑色素瘤起源于黑色素细胞,是鼻腔鼻窦区域的一种罕见恶性肿瘤。它是一种侵袭性黑色素细胞肿瘤,预后极差。症状无特异性,诊断常被延误,通常直至疾病晚期才得以确诊。本研究将鼻黏膜黑色素瘤的组织病理学特征与微环境中存在的不同类型免疫细胞进行关联分析,具有预后和治疗意义。研究终点是量化细胞免疫微环境并将其与患者生存期进行关联。本研究呈现了9例原发性鼻黏膜黑色素瘤病例,这些病例在罗马尼亚蒂米什瓦拉急救市医院于15年间被诊断。组织病理学检查在同一医院病理科进行,采用苏木精-伊红形态学染色。额外进行了免疫组化反应以确认诊断并评估肿瘤免疫微环境的组成部分。本研究确定嗜酸性粒细胞、巨噬细胞、NK 细胞和浆细胞为有利的预后因素。因此,CD8:CD4比值大于3与对PD-1抑制剂治疗的良好反应相关。

展开英文摘要原文

Sinonasal mucosal melanoma originates from melanocytes and it is a rare malignancy in the sinonasal tract. It is an aggressive melanocytic neoplasm with a very poor prognosis. The symptoms are nonspecific and the diagnosis is delayed, usually until the advanced stages of the disease.

The current study performs a correlation between the histopathological aspects of sinonasal mucosal melanoma and different types of immune cells present in the microenvironment, with prognostic and therapeutic implications. The endpoint is to quantify the cellular immune microenvironment and correlate it with patient survival.

This study presents nine cases of primary sinonasal mucosal melanomas diagnosed at the Emergency City Hospital Timisoara, Romania during a period of 15 years. The histopathological examination was performed in the Department of Pathology of the same hospital, using morphological hematoxylin-eosin staining. Additional immunohistochemical reactions were performed to confirm the diagnosis and evaluate the components of the tumor immune microenvironment.

This study identifies eosinophils, macrophages, natural killer cells and plasma cells as favorable prognostic factors.

Therefore, a CD8:CD4 ratio of more than 3 is correlated with a good response to PD-1 inhibitor therapy.

论文信息

作者
Trandafir CM、Closca RM、Poenaru M、Sarau OS、Sarau CA、Rakitovan M、Baderca F、Sima LV
第一作者单位
ENT Department, University of Medicine and Pharmacy "Victor Babes", 300041 Timisoara, Romania.Italy
通讯作者单位
Department of Surgery, University of Medicine and Pharmacy "Victor Babes", Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.Italy
期刊
Cancers2024 Aug 16
原文标识
PubMed 39199634 · DOI 10.3390/cancers16162863